Lakefront Biotherapeutics NV Sustainability Reports
The company is a clinical-stage biotechnology enterprise that develops medicines for patients with serious diseases in areas of unmet medical need, particularly focusing on oncology and immunology programs.
Sector: Professional & technical services
Country: Belgium
Exchange: Euronext Amsterdam
ISIN: BE0003818359
25 reports from 2006 to 2025